News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024April 11, 2025 InhaleRx has received Human Research Ethics Committee (HREC) approval to start a Phase II clinical trial […]
Cann Group extends deadline for cap raise as investors again told of ‘prosperous future’ by Steve Jones November 6, 2024April 11, 2025
Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue by Steve Jones October 30, 2024October 30, 2024
Cann Group faces more questions after reporting a bank balance of -$18,000 by Steve Jones October 23, 2024October 23, 2024
Cann Group goes back to investors in bid to raise $6.25m for product expansion by Steve Jones October 8, 2024October 8, 2024
Cann Group cites positive press coverage as possible reason for share price surge by Martin Lane September 30, 2024January 13, 2025
Company news: Cann Group; Helius Therapeutics/Novachem; Elixinol/HFA by Martin Lane September 4, 2024January 13, 2025
Cann Group considers capital raise and Mildura sale and leaseback as financial juggling act goes on by Steve Jones July 31, 2024July 31, 2024
